DK1435935T3 - Koncentreret røntgenkontrastmiddel, der kan agere som universelle antigener og kan inhibere eller forebygge allergiske reaktioner - Google Patents

Koncentreret røntgenkontrastmiddel, der kan agere som universelle antigener og kan inhibere eller forebygge allergiske reaktioner

Info

Publication number
DK1435935T3
DK1435935T3 DK02784074.3T DK02784074T DK1435935T3 DK 1435935 T3 DK1435935 T3 DK 1435935T3 DK 02784074 T DK02784074 T DK 02784074T DK 1435935 T3 DK1435935 T3 DK 1435935T3
Authority
DK
Denmark
Prior art keywords
contrast media
inhibit
act
antigens
ray contrast
Prior art date
Application number
DK02784074.3T
Other languages
English (en)
Inventor
Elliott Lasser Md
Original Assignee
Lasser Family Partnership L P
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lasser Family Partnership L P filed Critical Lasser Family Partnership L P
Application granted granted Critical
Publication of DK1435935T3 publication Critical patent/DK1435935T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
    • A61K49/0438—Organic X-ray contrast-enhancing agent comprising an iodinated group or an iodine atom, e.g. iopamidol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/7036—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin having at least one amino group directly attached to the carbocyclic ring, e.g. streptomycin, gentamycin, amikacin, validamycin, fortimicins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Otolaryngology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
DK02784074.3T 2001-10-12 2002-10-10 Koncentreret røntgenkontrastmiddel, der kan agere som universelle antigener og kan inhibere eller forebygge allergiske reaktioner DK1435935T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US32902701P 2001-10-12 2001-10-12
PCT/US2002/032467 WO2003030947A2 (en) 2001-10-12 2002-10-10 Concentrated x-ray contrast media can act as universal antigens and can inhibit or prevent allergic reactions

Publications (1)

Publication Number Publication Date
DK1435935T3 true DK1435935T3 (da) 2010-02-01

Family

ID=23283543

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02784074.3T DK1435935T3 (da) 2001-10-12 2002-10-10 Koncentreret røntgenkontrastmiddel, der kan agere som universelle antigener og kan inhibere eller forebygge allergiske reaktioner

Country Status (10)

Country Link
US (3) US6951641B2 (da)
EP (1) EP1435935B1 (da)
JP (1) JP4707952B2 (da)
AT (1) ATE443514T1 (da)
AU (1) AU2002347863A1 (da)
DE (1) DE60233812D1 (da)
DK (1) DK1435935T3 (da)
ES (1) ES2334340T3 (da)
PT (1) PT1435935E (da)
WO (1) WO2003030947A2 (da)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080275128A1 (en) * 2007-04-27 2008-11-06 Elliott C Lasser Compositions and methods for the treatment of inflammatory conditions
US8551449B2 (en) * 2007-10-30 2013-10-08 Ge Healthcare As Contrast agents
EP2205553A1 (en) * 2007-11-07 2010-07-14 GE Healthcare AS Contrast agents
US20130071335A1 (en) * 2011-09-20 2013-03-21 Elliott C. Lasser X-ray contrast media compositions and methods of using the same
US20130071490A1 (en) * 2011-09-20 2013-03-21 Elliott C. Lasser X-ray contrast media compositions and methods of using the same to treat, reduce or delay the onset of cns inflammation and inflammation associated conditions
US8915399B1 (en) 2012-11-06 2014-12-23 Acist Medical Systems, Inc. Simulated contrast injection medium
JP2016503410A (ja) * 2012-11-09 2016-02-04 スリーイー セラピューティクス コーポレイション３Ｅ Ｔｈｅｒａｐｅｕｔｉｃｓ Ｃｏｒｐｏｒａｔｉｏｎ Ｘ線造影剤組成物およびそれを使用して炎症関連症状を治療する方法
WO2016054658A1 (en) * 2014-10-03 2016-04-07 3E Therapeutics Corporation Use of x-ray contrast media and related compositions for the treatment and prevention of a filovirus infection

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE41415T1 (de) * 1984-05-24 1989-04-15 Ciba Geigy Ag Neue resorcinaether.
CA2000177A1 (en) 1988-10-13 1990-04-13 Ronald E. Wyrick Predicting sensitivity to injectable radio contrast media with a histamine release test
JPH02218959A (ja) * 1988-10-13 1990-08-31 Miles Inc ヒスタミン放出試験を用いる注射性ｘ線撮影造影剤に対する感受性の予測方法

Also Published As

Publication number Publication date
JP2005523880A (ja) 2005-08-11
US7151117B2 (en) 2006-12-19
WO2003030947A3 (en) 2004-02-19
US7838557B2 (en) 2010-11-23
US20040198834A1 (en) 2004-10-07
AU2002347863A1 (en) 2003-04-22
US20060002858A1 (en) 2006-01-05
ATE443514T1 (de) 2009-10-15
ES2334340T3 (es) 2010-03-09
EP1435935B1 (en) 2009-09-23
US6951641B2 (en) 2005-10-04
PT1435935E (pt) 2009-12-29
WO2003030947A2 (en) 2003-04-17
JP4707952B2 (ja) 2011-06-22
EP1435935A2 (en) 2004-07-14
DE60233812D1 (de) 2009-11-05
US20070088087A1 (en) 2007-04-19

Similar Documents

Publication Publication Date Title
WO2003106644A3 (en) RESPIRATORY SYNCYTIAL ANTI-VIRUS ANTIBODY FORMULATIONS (RSV) STABILIZED
DK1435935T3 (da) Koncentreret røntgenkontrastmiddel, der kan agere som universelle antigener og kan inhibere eller forebygge allergiske reaktioner
AR048599A1 (es) Anticuerpos anti-p-selectina
CY1109528T1 (el) Μεθοδος και συσκευη για εξωτερικη σταθεροποιηση καρδιας
TR200102739T2 (tr) Aşı
AR025247A1 (es) Composiciones de granulos de carotenos-xantofilos, estables
CO2022012212A2 (es) Anticuerpos anti-cd19 humano
MX2022004218A (es) Proteina de fusion multiespecifica y uso de la misma.
WO2022226342A3 (en) Modified anti-tslp antibodies
ATE180512T1 (de) Peptidfragmente des menschlichen cytochrome p450 iid6, antikörper dagegen und ihre verwendungen in diagnostik
PE20010454A1 (es) Articulo absorbente con mecanismo que se puede volver a pegar
EA200501752A1 (ru) Композиции и способы чернения и придания коррозионно-стойких свойств цинку или другим активным металлам
KUSMIATI PENINGKATAN KEMAMPUAN SENI DALAM PEMBELAJARAN MELUKIS DENGAN TEKNIK USAP ABUR ANAK KELOMPOK B
DK1796730T3 (da) Stabiliseret leukotrien B4 (LTB4) farmaceutisk middel
UA135457U (uk) Драже арахіс в карамелі з французькою гірчицею
BR0212289A (pt) Anticorpos contra caspase-8, preparação e uso do mesmo
JP2002370949A5 (da)
DK358584A (da) Carbamater og oxalamider af amino-n-(1h-tetrazol-5-yl)-benzamider
Maheshwari Out of the box: Protect the Unprotected
Islami et al. An Explanation about the Problem of “the Possibility of Motion in Abstract Beings” and Reply to its Bugs
浅香有希子 Associations of Socioeconomic Status, Family Environment and Lifestyle Factors with Dental Caries of Elementary School Children: The MEXT Super Shokuiku School Project.
Nekrasova et al. DYNAMIC PAUSES AS A FORM OF FULL-FLEDGED PHYSICAL DEVELOPMENT AND HEALTH PROMOTION OF PRESCHOOLERS
MA28442B1 (fr) Avocatier denomme 'mendez n°.1'
Viktoriia STRUCTURAL PECULIARITIES OF PAREMIAS WITH THE COMPONENT “CALENDAR CHRONONYM” IN THE UKRAINIAN LANGUAGE
Shriram THE PHOTO BEACON 04-09-2021